Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|November 24, 2007
Gene therapy for chronic granulomatous diseaseMartin F Ryser, Joachim Roesler, Marcus Gentsch, et al.
Molecular Immunology|September 2, 2008
S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homingMartin F Ryser, Fernando Ugarte, Romy Lehmann, et al.
International Journal of Hematology|March 3, 2009
Serum albumin strongly influences SDF-1 dependent migrationMartin F Ryser, Sebastian Thieme, Martin Bornhäuser, et al.
Tissue Engineering. Part C, Methods|August 13, 2008
mRNA transfection of CXCR4-GFP fusion--simply generated by PCR-results in efficient migration of primary human mesenchymal stem cellsMartin F Ryser, Fernando Ugarte, Sebastian Thieme, et al.
Stem Cells (Dayton, Ohio)|April 28, 2007
The late dividing population of gamma-retroviral vector transduced human mobilized peripheral blood progenitor cells contributes most to gene-marked cell engraftment in nonobese diabetic/severe combined immunodeficient miceSebastian Brenner, Martin F Ryser, Narda L Whiting-Theobald, et al.
Stem Cells (Dayton, Ohio)|December 8, 2004
CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cellsSebastian Brenner, Narda Whiting-Theobald, Toshinao Kawai, et al.
Vaccine|May 14, 2024
Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trialSant Muangnoicharoen, Rakpong Wiangcharoen, Saranath Lawpoolsri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2006
Polyclonal long-term MFGS-gp91phox marking in rhesus macaques after nonmyeloablative transplantation with transduced autologous peripheral blood progenitor cellsSebastian Brenner, Martin F Ryser, Uimook Choi, et al.
Vaccine|June 21, 2023
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trialSant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, et al.
Mayo Clinic Proceedings|July 15, 2025
Responses of Kidney Transplant Recipients to Vaccination and BoostingWalter D Park, Sumi S Nair, Hani M Wadei, et al.
Pageof 2